BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 25149153)

  • 1. Therapeutic potential of siRNA and DNAzymes in cancer.
    Karnati HK; Yalagala RS; Undi R; Pasupuleti SR; Gutti RK
    Tumour Biol; 2014 Oct; 35(10):9505-21. PubMed ID: 25149153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNAzymes as potential therapeutic molecules.
    Isaka Y
    Curr Opin Mol Ther; 2007 Apr; 9(2):132-6. PubMed ID: 17458166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct inhibitory efficiency of siRNAs and DNAzymes to β1 integrin subunit in blocking tumor growth.
    Wiktorska M; Sacewicz-Hofman I; Stasikowska-Kanicka O; Danilewicz M; Niewiarowska J
    Acta Biochim Pol; 2013; 60(1):77-82. PubMed ID: 23513189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNAzymes, Novel Therapeutic Agents in Cancer Therapy: A Review of Concepts to Applications.
    Thomas IBK; Gaminda KAP; Jayasinghe CD; Abeysinghe DT; Senthilnithy R
    J Nucleic Acids; 2021; 2021():9365081. PubMed ID: 34760318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNAzymes as molecular agents that manipulate Egr-1 gene expression.
    Khachigian LM
    Biochem Pharmacol; 2004 Sep; 68(6):1023-5. PubMed ID: 15313396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNAzyme-based therapeutics for cancer treatment.
    Fu S; Sun LQ
    Future Med Chem; 2015; 7(13):1701-7. PubMed ID: 26381244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNAzyme technology and cancer therapy: cleave and let die.
    Dass CR; Choong PF; Khachigian LM
    Mol Cancer Ther; 2008 Feb; 7(2):243-51. PubMed ID: 18281510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deoxyribozymes as Catalytic Nanotherapeutic Agents.
    Khachigian LM
    Cancer Res; 2019 Mar; 79(5):879-888. PubMed ID: 30760521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-based therapeutics and DNA delivery systems: a comprehensive review.
    Patil SD; Rhodes DG; Burgess DJ
    AAPS J; 2005 Apr; 7(1):E61-77. PubMed ID: 16146351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribozymes, DNAzymes and small interfering RNAs as therapeutics.
    Sioud M; Iversen PO
    Curr Drug Targets; 2005 Sep; 6(6):647-53. PubMed ID: 16178798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small interfering RNA therapy in cancer: mechanism, potential targets, and clinical applications.
    Huang C; Li M; Chen C; Yao Q
    Expert Opin Ther Targets; 2008 May; 12(5):637-45. PubMed ID: 18410245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promising approaches of small interfering RNAs (siRNAs) mediated cancer gene therapy.
    Senapati D; Patra BC; Kar A; Chini DS; Ghosh S; Patra S; Bhattacharya M
    Gene; 2019 Nov; 719():144071. PubMed ID: 31454539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.
    Miele E; Spinelli GP; Miele E; Di Fabrizio E; Ferretti E; Tomao S; Gulino A
    Int J Nanomedicine; 2012; 7():3637-57. PubMed ID: 22915840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA enzymes as potential therapeutics: towards clinical application of 10-23 DNAzymes.
    Fokina AA; Stetsenko DA; François JC
    Expert Opin Biol Ther; 2015 May; 15(5):689-711. PubMed ID: 25772532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in Oligonucleotide Therapeutics in Oncology.
    Xiong H; Veedu RN; Diermeier SD
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33804856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Transport Systems and Clinical Applications for Small Interfering RNA (siRNA) Drugs.
    Liu F; Wang C; Gao Y; Li X; Tian F; Zhang Y; Fu M; Li P; Wang Y; Wang F
    Mol Diagn Ther; 2018 Oct; 22(5):551-569. PubMed ID: 29926308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image-Guided Nanoparticle-Based siRNA Delivery for Cancer Therapy.
    Kim YD; Park TE; Singh B; Maharjan S; Cho KS; Park KP; Choi YJ; Arote RB; Cho CS
    Curr Pharm Des; 2015; 21(31):4637-56. PubMed ID: 26486148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense applications for biological control.
    Pan WH; Clawson GA
    J Cell Biochem; 2006 May; 98(1):14-35. PubMed ID: 16440307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innovations in siRNA research: a technology comes of age.
    Hefferon KL
    Recent Pat Antiinfect Drug Discov; 2010 Nov; 5(3):226-39. PubMed ID: 20812899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small interfering RNA-based molecular therapy of cancers.
    Guo W; Chen W; Yu W; Huang W; Deng W
    Chin J Cancer; 2013 Sep; 32(9):488-93. PubMed ID: 23327796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.